{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:03:53Z","timestamp":1779757433393,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010086","name":"Foundation of Liaoning Province Education Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114928","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:30:28Z","timestamp":1776108628000},"page":"114928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual-action ROS-responsive nanoparticles for synergistic suppression of pyroptosis and cfDNA in inflammatory bowel diseases"],"prefix":"10.1016","volume":"394","author":[{"given":"Chang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114928_bb0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0010","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/s41591-021-01551-y","article-title":"Finding the right target for drug-resistant inflammatory bowel disease","volume":"27","author":"Cader","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114928_bb0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12935-023-03117-z","article-title":"Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer","volume":"23","author":"Deris Zayeri","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2026.114928_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102382","article-title":"Innate immunity as the trigger of systemic autoimmune diseases","volume":"110","author":"Saferding","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2026.114928_bb0025","article-title":"Loss of response to anti-TNFs: definition, epidemiology, and management, clinical and translational","volume":"7","author":"Roda","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.114928_bb0030","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41401-023-01123-5","article-title":"Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics","volume":"44","author":"Jin","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114928_bb0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"McInnes","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0040","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41565-024-01759-2","article-title":"Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114928_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114928_bb0060","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.immuni.2023.10.004","article-title":"Gasdermin d permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis","volume":"56","author":"Miao","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114928_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6717","article-title":"Gasdermin d in macrophages restrains colitis by controlling cGAS-mediated inflammation","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114928_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41577-018-0117-0","article-title":"DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer","volume":"19","author":"Paludan","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1516465112","article-title":"Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114928_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06603-5","article-title":"Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation","volume":"9","author":"Liang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114928_bb0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/emboj.2011.441","article-title":"DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature","volume":"31","author":"Li","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2026.114928_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2019.02.007","article-title":"Pharmacological modulation of the STING pathway for cancer immunotherapy","volume":"25","author":"Berger","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114928_bb0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS\u2013STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2019.01255","article-title":"Targeting macrophages: friends or foes in disease?","volume":"10","author":"Ardura","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114928_bb0110","doi-asserted-by":"crossref","first-page":"21116","DOI":"10.1021\/acsnano.3c04819","article-title":"An orally-administered nanotherapeutics with carbon monoxide supplying for inflammatory bowel disease therapy by scavenging oxidative stress and restoring gut immune homeostasis","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114928_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115138","article-title":"Identification of novel biomarkers linked to m1 macrophage infiltration in the diagnosis of inflammatory bowel diseases","volume":"162","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0130","doi-asserted-by":"crossref","first-page":"2000391","DOI":"10.1002\/adfm.202000391","article-title":"Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis","volume":"30","author":"Wu","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114928_bb0135","first-page":"230","article-title":"C-176 loaded ce DNase nanoparticles synergistically inhibit the cGAS-STING pathway for ischemic stroke treatment","volume":"29","author":"Zhu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114928_bb0140","first-page":"37","article-title":"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment","volume":"24","author":"Shen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114928_bb0145","doi-asserted-by":"crossref","first-page":"2407115","DOI":"10.1002\/adma.202407115","article-title":"Pyroptotic-spatiotemporally selective delivery of siRNA against pyroptosis and autoimmune diseases","volume":"36","author":"Pan","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114928_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","article-title":"Metabolic reprogram and t cell differentiation in inflammation: current evidence and future perspectives","volume":"11","author":"Shi","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jconrel.2026.114928_bb0155","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.2147\/JIR.S534447","article-title":"Macrophage metabolic reprogramming in inflammatory bowel diseases: from pathogenesis to therapy","volume":"18","author":"Zhang","year":"2025","journal-title":"JIR"},{"key":"10.1016\/j.jconrel.2026.114928_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108756","article-title":"Itaconate confers tolerance to late NLRP3 inflammasome activation","volume":"34","author":"Bambouskova","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114928_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114928_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102553","article-title":"The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases","volume":"58","author":"Shi","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2026.114928_bb0175","article-title":"4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114928_bb0180","doi-asserted-by":"crossref","first-page":"16658","DOI":"10.1021\/acsnano.4c01520","article-title":"Alleviating pyroptosis of intestinal epithelial cells to restore mucosal integrity in ulcerative colitis by targeting delivery of 4-octyl-itaconate","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114928_bb0185","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1039\/D2BM01894B","article-title":"Injectable hydrogel loaded with 4-octyl itaconate enhances cartilage regeneration by regulating macrophage polarization","volume":"11","author":"Xiao","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114928_bb0190","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.7150\/thno.70623","article-title":"Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114928_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.actbio.2020.04.052","article-title":"Design of light\/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy","volume":"111","author":"Zuo","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114928_bb0200","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","article-title":"Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:49:28Z","timestamp":1779756568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0168365926003317"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114928","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-action ROS-responsive nanoparticles for synergistic suppression of pyroptosis and cfDNA in inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114928"}}